Results of a prospective study of positron emission tomography-directed management of residual nodal abnormalities in node-positive head and neck cancer after definitive radiotherapy with or without systemic therapy
File version
Author(s)
I. Pryor, David
Burmeister, Elizabeth
Burmeister, Bryan H.
G. Poulsen, Michael
C. Foote, Matthew
Panizza, Benedict
Coman, Scott
McFarlane, David
Coman, William
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
Size
File type(s)
Location
License
Abstract
Background. The purpose of this study was to present our prospectively evaluated positron emission tomography (PET)-directed policy for managing the neck in nodepositive head and neck squamous cell carcinoma (NSCC) after definitive radiotherapy (RT) with or without concurrent systemic therapy. Methods. One hundred twelve consecutive patients who achieved a complete response at the primary site underwent a 12-week posttherapy nodal response assessment with PET and diagnostic CT. Patients with an equivocal PET underwent a repeat PET 4 to 6 weeks later. Patients with residual CT nodal abnormalities deemed PET-negative were uniformly observed regardless of residual nodal size. Results. Median follow-up from commencement of RT was 28 months (range, 13-64 months). Residual CT nodal abnormalities were present in 50 patients (45%): 41 PET-negative and 9 PET-positive. All PET-negative residual CT nodal abnormalities were observed without subsequent isolated nodal failure. Conclusion. PET-directed management of the neck after definitive RT in node-positive HNSCC appropriately spares neck dissections in patients with PET-negative residual CT nodal abnormalities.
Journal Title
Head & Neck
Conference Title
Book Title
Edition
Volume
33
Issue
12
Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
Item Access Status
Note
Access the data
Related item(s)
Subject
Medical and Health Sciences not elsewhere classified
Clinical Sciences
Dentistry